| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | SVP, Drug Development
1 company
Rosenbaum David P. is a Chief Development Officer at ARDELYX, INC.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 7,184 | $4.79 | $34,443.69 | -1.6% | +30.5% | +12.8% | |
| Nov 6, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sale+OE | 27,171 | $6.10 | $165,743.10 | -15.0% | -14.9% | -12.9% | |
| Nov 4, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sale+OE | 27,172 | $5.95 | $161,673.40 | -15.0% | -10.2% | -4.9% | |
| Sep 27, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 49,564 | $6.92 | $342,982.88 | -14.1% | -27.7% | -16.7% | |
| Sep 13, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 5,312 | $6.26 | $33,253.65 | -3.3% | -17.0% | +4.8% | |
| Aug 20, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 7,219 | $5.86 | $42,305.51 | -1.4% | -19.0% | -2.1% | |
| Aug 20, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sale+OE | 40,507 | $5.97 | $241,782.00 | -7.3% | -19.0% | -2.1% | |
| Jun 3, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 17,872 | $7.00 | $125,104.00 | -10.1% | -18.6% | -43.2% | |
| May 21, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 7,053 | $7.81 | $55,090.98 | -1.3% | -22.4% | -48.3% | |
| Feb 26, 2024 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 5,183 | $9.20 | $47,683.60 | -2.9% | -25.7% | -44.2% |